Randomised clinical trial evaluating best-corrected visual acuity and central macular thickness after 532-nm subthreshold laser grid photocoagulation treatment in diabetic macular oedema

PURPOSE: To compare best-corrected visual acuity (BCVA) and central macular thickness (CMT) after 532-nm subthreshold laser grid photocoagulation and threshold laser grid photocoagulation for the treatment of diabetic macular oedema (DME). PATIENTS AND METHODS: Twenty-three patients (46 eyes) with b...

Descripción completa

Detalles Bibliográficos
Autores principales: Pei-pei, W, Shi-zhou, H, Zhen, T, Lin, L, Ying, L, Jiexiong, O, Wen-bo, Z, Chen-jin, J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2015
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366477/
https://www.ncbi.nlm.nih.gov/pubmed/25697457
http://dx.doi.org/10.1038/eye.2015.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366477/
https://www.ncbi.nlm.nih.gov/pubmed/25697457
http://dx.doi.org/10.1038/eye.2015.1

Ejemplares similares